Physical Performance
Conditions
Interventions
This is a randomized, controlled, double-blind, two-arm clinical trial. The Caffeine Group (CA) will consist of 10 healthy men who will receive, 60 minutes before the assessments, a dose of 0.6 g/kg o
Sponsors
Universidade Federal de Lavras
Universidade Federal de Lavras
Eligibility
Sex/Gender
Male
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Male individuals who regularly practice physical activity; Age between 18 and 35 years; Regular practice of physical activity for at least 24 months
Exclusion criteria
Exclusion criteria: Smoker; Patients with diabetes and/or cardiovascular diseases; History of osteoarticular injury in the last six months. Use of any ergogenic resource and / or dietary supplement; Failure to attend LEMOH or the Sports Nutrition Laboratory on the days of tests
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The acute ingestion of 210 mg of caffeine proved to be effective in improving the performance of The acute ingestion of 210 mg of caffeine will be effective in improving the performance of CrossFit® practitioners when performing a benchmark of the modality, reducing completion time and lower limb power. | — |
Secondary
| Measure | Time frame |
|---|---|
| Acute caffeine supplementation will bring benefits to the subjective perception of exertion (RPE), delayed onset muscle soreness (DOMS) and muscle thickness. | — |
Countries
Brazil
Contacts
Public ContactSandro da Silva
Universidade Federal de Lavras
Outcome results
None listed